Asia Pacific Pharmaceutical Contract Sales Organizations Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), and End User (Biopharmaceutical Companies and Pharmaceutical Companies)

No. of Pages: 88
Report Code: BMIRE00030019
Category: Life Sciences
Asia Pacific Pharmaceutical Contract Sales Organizations Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Regional Analysis

6.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast Analysis

7. Asia Pacific Pharmaceutical Contract Sales Organizations Market Analysis – by Services

7.1 Commercial Services
  • 7.1.1 Overview
  • 7.1.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Non-Commercial Services
  • 7.2.1 Overview
  • 7.2.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific Pharmaceutical Contract Sales Organizations Market Analysis – by Modules

8.1 Syndicated Modules
  • 8.1.1 Overview
  • 8.1.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Dedicated Modules
  • 8.2.1 Overview
  • 8.2.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Analysis – by Therapeutic Area

9.1 Cardiovascular Disorders
  • 9.1.1 Overview
  • 9.1.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Oncology
  • 9.2.1 Overview
  • 9.2.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Metabolic Disorders
  • 9.3.1 Overview
  • 9.3.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Neurology
  • 9.4.1 Overview
  • 9.4.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Orthopedic Diseases
  • 9.5.1 Overview
  • 9.5.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Infectious Diseases
  • 9.6.1 Overview
  • 9.6.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific Pharmaceutical Contract Sales Organizations Market Analysis – by End User

10.1 Biopharmaceutical Companies
  • 10.1.1 Overview
  • 10.1.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Pharmaceutical Companies
  • 10.2.1 Overview
  • 10.2.2 Pharmaceutical Companies : Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Asia Pacific Pharmaceutical Contract Sales Organizations Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific
  • 11.2.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 11.2.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.1.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
    • 11.2.1.1.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
    • 11.2.1.1.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
    • 11.2.1.1.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
  • 11.2.1.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.2.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
    • 11.2.1.2.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
    • 11.2.1.2.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
    • 11.2.1.2.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
  • 11.2.1.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
    • 11.2.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
    • 11.2.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
    • 11.2.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
  • 11.2.1.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.4.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
    • 11.2.1.4.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
    • 11.2.1.4.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
    • 11.2.1.4.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
  • 11.2.1.5 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
    • 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
    • 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
    • 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Contract Sales Organizations Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Aenova Holding GmbH
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 CMIC Holdings Co Ltd
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 EPS Holdings Inc
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 IQVIA Holdings Inc
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Mednext Pharmaceuticals Pvt Ltd
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Pfizer Inc
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Syneos Health Inc
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Asia Pacific Pharmaceutical Contract Sales Organizations Market

  • Aenova Holding GmbH
  • CMIC Holdings Co Ltd
  • EPS Holdings Inc
  • IQVIA Holdings Inc
  • Mednext Pharmaceuticals Pvt Ltd
  • Pfizer Inc
  • Syneos Health Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)